APOLLO HOSPITALS ENTER. L

Operates a hospital-based healthcare business alongside a large pharmacy distribution network and a retail diagnostics chain. In FY26, total revenue was Rs 25,228.5 crore with net profit of Rs 2,002.7 crore. The Healthcare services segment contributed 50.1% of segment revenue (Rs 12,750.1 crore) at a 19.1% EBIT margin, while Digital health & pharmacy distribution contributed 42.5% (Rs 10,808.1 crore) at a 3.7% EBIT margin, and Retail health & diagnostics contributed 7.3% (Rs 1,865.3 crore) at a 3.9% EBIT margin. Major cost lines are other operating expenses at 21.3% of revenue, materials at 12.1% and employee costs at 11.9%, with depreciation at 3.5% and capex of Rs 1,962.0 crore (7.8% of revenue) in the year. The company has filed a composite scheme of arrangement to demerge an identified business undertaking (including Apollo Healthco and Keimed) into a new listed entity called Apollo Healthtech, with equity shareholders having approved the scheme at NCLT-convened meetings in June 2026.